from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3346c/-

LFCtreatmentdescriptionclass of inhibitor

-0.125

Amikacinug/mL Amikacintranslation

0.356

Cap5-10ug/mL Capreomycintranslation

0.760

Rox10-50 ug/mL Roxithromycintranslation

0.250

SM2-5 ug/mL Streptomycintranslation

0.174

Tet5-10 ug/mL Tetracyclinetranslation

0.021

Rif0.2-5ug/mL Rifampicintranscription

-0.809

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.431

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.003

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.625

CPZ10-50 ug/mL Chlorpromazinerespiration

0.807

Clofazimine10-13 ug/mL Clofaziminerespiration

0.306

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.069

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.748

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.235

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.566

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.250

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.011

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.154

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-3.047

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.406

KCN5-20 ug/mL Potassium cyaniderespiration

-0.150

NaN30.2-2 mM Sodium aziderespiration

-2.196

Nigericin50 uM Nigericinrespiration

0.424

TRC10-150 ug/mL Triclosanrespiration

0.429

TRZ10-25 ug/mL Thioridazinerespiration

-0.704

Valinomycin0.5-10 uM Valinomycinrespiration

-3.004

ZnSO42 mM ZnSO4respiration

-1.047

menadione6-10 ug/mL Menadionerespiration

0.218

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.424

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.084

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.046

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.261

NRP_1Non-replicating persistence stage 1dosRassociated

-0.014

Amp0.2mg/mL AmpicillincellWall

-0.155

Cephalexin20-100 ug/mL CephalexincellWall

0.139

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.895

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.368

EMB10-20 ug/mL EthambutolcellWall

0.098

Eta12-40 ug/mL EthionamidecellWall

0.234

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.463

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.597

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.087

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.230

BZA0.12 mg/mL BenzamidearomaticAmides

1.156

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.143

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.662

H2O24 mM hydrogen peroxideDNAdamaging

-0.070

Levo10 ug/mL LevofloxacinDNAdamaging

-0.319

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.438

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.425

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.201

UVUV-irradiationDNAdamaging

0.684

ARP41-4 ug/mL Antitubercular compound ARP4?

0.163

Antimycin12.5-50 ug/mL Antimycin A?

-1.045

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.545

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.265

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.607

PA8240.2-2 ug/mL PA-824?

-0.185

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.192

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.938

Verapamil50 uM Verapamil?

-1.846

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.275

methoxatin10-20 ug/mL Methoxatin?